Aluminum polymeric implants: in vitro-in vivo evaluations

Area of Science:

• Biomaterials Science
• Toxicology
• Neuroscience

Background:

• Aluminum accumulation in tissues is linked to neurological disorders.
• Developing reliable animal models is crucial for studying diseases like dementia.
• Polymeric implants offer controlled release of substances.

Purpose of the Study:

• To investigate aluminum release and tissue accumulation from long-term subcutaneous polymeric implants in rats.
• To assess the safety and efficacy of aluminum polymeric implants for potential use in animal models.
• To determine the impact of these implants on aluminum levels in key organs.

Main Methods:

• Formulation of implants using silicone rubber, polyurethane, and aluminum salts.
• In vitro release studies of aluminum from polymeric matrices over four months.
• Subcutaneous implantation of aluminum matrices in rats, with sacrifice at various time points.
• Neutron Activation Analysis (NAA) to quantify aluminum in isolated brain, kidney, liver, intestine, and heart tissues.

Main Results:

• Polymeric aluminum implants demonstrated aluminum release in vitro for up to four months.
• Significant increases in aluminum concentration were observed in the brain and liver tissues of implanted rats.
• No significant elevation in aluminum levels was found in the intestine, heart, or kidney tissues.

Conclusions:

• Subcutaneous polymeric aluminum implants effectively increase aluminum concentrations in the brain and liver in a rat model.
• These implants do not lead to systemic aluminum overload in other major organs.
• The developed aluminum implants show potential for creating a relevant animal model for studying dementia-related neuropathology.